VivoSim Labs (VIVS) Assets Average (2011 - 2026)
VivoSim Labs (VIVS) posted quarterly Assets Average of $7.2 million for Q1 2026, down 22.43% year-over-year from $9.2 million in Q1 2025, and down 13.82% quarter-over-quarter from $8.3 million in Q4 2025.
VivoSim Labs (VIVS) Assets Average (2011 - 2026) Analysis & Trends
VivoSim Labs' Assets Average history runs 16 years deep, the most recent figure standing at $7.2 million for Q1 2026.
- In Q1 2026, Assets Average fell 22.43% year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $7.2 million (down 22.43% YoY), while the FY2026 annual figure was $11.0 million, up 4.94% from the prior year.
- Assets Average for Q1 2026 stood at $7.2 million, down from $8.3 million in the prior quarter.
- The five-year high for Assets Average was $34.2 million in Q1 2022, with the low at $5.3 million in Q4 2024.
- The 5-year median for Assets Average is $10.0 million (2023), against an average of $15.0 million.
- The sharpest annual moves came in 2023 and 2025: Assets Average sank 70.05% in 2023, then jumped 68.33% in 2025.
- VivoSim Labs' Assets Average stood at $26.5 million in 2022, then slumped by 62.18% to $10.0 million in 2023, then tumbled by 47.12% to $5.3 million in 2024, then jumped by 57.07% to $8.3 million in 2025, then retreated by 13.82% to $7.2 million in 2026.
- Business Quant data shows VIVS's Assets Average at $7.2 million in Q1 2026, $8.3 million in Q4 2025, and $10.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - | 19.82 Bn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 5.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.62 Mn |
| Mar 31, 2026 | 7.17 Mn |
| Dec 31, 2025 | 8.32 Mn |
| Sep 30, 2025 | 10.83 Mn |
| Jun 30, 2025 | 13.31 Mn |
| Mar 31, 2025 | 9.25 Mn |
| Dec 31, 2024 | 5.30 Mn |
| Sep 30, 2024 | 8.11 Mn |
| Jun 30, 2024 | 7.91 Mn |
| Mar 31, 2024 | 7.62 Mn |
| Dec 31, 2023 | 10.02 Mn |
| Sep 30, 2023 | 8.76 Mn |
| Jun 30, 2023 | 13.33 Mn |
| Mar 31, 2023 | 22.70 Mn |
| Dec 31, 2022 | 26.49 Mn |
| Sep 30, 2022 | 29.23 Mn |
| Jun 30, 2022 | 31.92 Mn |
| Mar 31, 2022 | 34.20 Mn |
| Dec 31, 2021 | 35.49 Mn |
| Sep 30, 2021 | 37.09 Mn |